Press releases
Would you like to join our media distribution list or receive electronic copies of our press releases? Would you like to know more about the HOCHDORF Group? Please contact:
Marlène Betschart
Head Corporate Communication & Investor Relations
HOCHDORF-Gruppe
Tel. +41 41 914 65 83
Mobile +41 79 245 24 10
marlene.betschart@hochdorf.com
Would you like to learn more about us? You are welcome to read our customer magazine "HOCHDORF Inside".
- 22.04HOCHDORF publishes agenda for the Annual General Meeting and provides information on financial legacy and prospects
- 21.03Positive operating result for HOCHDORF – approach of investors launched
- 05.03HOCHDORF: Update on 2023 business performance and strategic options for financial restructuring
- 11.09Hochdorf production site to remain in operation until the end of 2026
- 24.08HOCHDORF on course operationally: pleasing first half year
- 23.03HOCHDORF makes significant operational progress and gains time
- 15.11CFO change at the HOCHDORF Group
- 08.08HOCHDORF: Pleasing net sales revenue – material and energy costs negatively influence half-year result
- 22.06CFO change at the HOCHDORF Group
- 14.03Pleasing balance sheet improvement and difficult milk year
- 21.01Peter Pfeilschifter to leave HOCHDORF Swiss Nutrition Ltd - Ralph Siegl appointed CEO
- 16.12HOCHDORF sells site to the Hochdorf municipality
- 31.08HOCHDORF takes next steps towards financial recovery and strategic focus
- 16.08Interim Results 2021: Creating a solid foundation for a successful future
- 28.06HOCHDORF reaches agreement with syndicate banks
- 09.06Shareholders accept Board of Directors’ recommendations
- 12.04HOCHDORF – strategic and operational foundations developed
- 10.03HOCHDORF postpones Annual Results Press Conference and Annual General Meeting
- 18.12HOCHDORF to sell Marbacher Ölmühle
- 01.10HOCHDORF extends deadline for part of the final payment from the sale of Pharmalys
- 23.09HOCHDORF and BIMBOSAN move together to strengthen the "Bimbosan" brand
- 17.08Recent measures are taking effect
- 22.072020 interim results better than previous year
- 30.06Jürg Oleas is elected as Chair of the Board of Directors
- 25.06Geza Somogyi appointed COO of the HOCHDORF Group
- 15.06Answers to the shareholder questions to the AGM on Agenda Item 8
- 05.06Information about the Annual General Meeting on 30 June 2020
- 25.05Nanette Haubensak appointed CFO of the HOCHDORF Group
- 06.05HOCHDORF Group continues to sharpen its focus
- 19.032019: A challenging year of transformation
- 26.02HOCHDORF to part from German milk plant
- 18.02Board of Directors of HOCHDORF must be recomposed
- 16.01Our response to questions raised by Stichting General Holdings
- 19.12Dr Peter Pfeilschifter appointed CEO of the HOCHDORF Group
- 19.12HOCHDORF Group receives motion to convene Extraordinary General Meeting
- 13.12Closing of the sale of the Pharmalys stake to Pharmalys Invest Holding
- 08.12HOCHDORF sells Pharmalys stake to Pharmalys Invest Holding
- 14.11Jürgen Brandt appointed new CFO of the HOCHDORF Group
- 21.08Amir Mechria resigns from the Board of Directors of Pharmalys Laboratories SA
- 20.08HOCHDORF must realign itself
- 07.08Sale of HOCHDORF South Africa Ltd
- 08.07HOCHDORF realigns its business
- 13.05Integration of subsidiaries bigger challenge than expected – strategy update announced
- 12.04Shareholders focus on fresh impetus – HOCHDORF receives four new board members
- 19.03Implementation of strategy continues – expected earnings not yet realised
- 13.03Nominations for the Board of Directors
- 11.03Dr Thomas Eisenring resigns as CEO
- 10.12Sales delays and inventory write-downs impact net income
- 21.11Milk from Eastern Switzerland for HOCHDORF infant formula
- 30.08HOCHDORF expecting a significant improvement in the second half of the year
- 18.07Michel Burla to leave the HOCHDORF Group at the end of this year
- 19.06HOCHDORF parts company with milk plant in Lithuania
- 24.05HOCHDORF takes over traditional Swiss brand Bimbosan
- 07.05Dividend increase thanks to good result
- 05.04HOCHDORF: Successful forward integration
- 29.03Werner Schweizer is succeeded by Dr Peter Pfeilschifter
- 31.01Dr Karl Gschwend to retire
- 21.11HOCHDORF successfully places public hybrid bond (SIX/
- 14.11HOCHDORF presents a new quality standard for oils
- 01.11HOCHDORF strengthens its position in Cereals & Ingredients
- 17.08Higher earnings thanks to Pharmalys’ participation
- 04.07Uckermärker Milch to reposition itself on the market
- 08.05Dr Daniel Suter takes on the role of Chairman
- 28.03Closing of the Offering
- 13.03Launch of the mandatory convertible securities
- 13.03HOCHDORF posts record earnings in 2016
- 26.01Sales maintained at last year’s level despite low milk price